EPILAT-IRA Study: A contribution to the understanding of the epidemiology of acute kidney injury in Latin America

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Autores
LOMBARDI, Raul
FERREIRO, Alejandro
GRANADO, Rolando Claure-Del
ROSA-DIEZ, Guillermo
YOUNES-IBRAHIM, Mauricio
CARLINO, Cristina
CHAVEZ-INIGUEZ, Jonathan S.
PEREIRE, Mariana B.
Citação
PLOS ONE, v.14, n.11, article ID e0224655, 14p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction Epidemiology of acute kidney injury (AKI) is highly dependent on patient characteristics, context and geography. Considering the limited information in Latin America and the Caribbean, we performed a study with the aim to contribute to improve its better understanding. Methods Observational, prospective, longitudinal, multinational cohort study addressed to determine risk factors, clinical profile, process of care and outcomes of AKI in the region. Patients meeting KDIGO AKI definition were included over a 9-month period and designated community or hospital-acquired. De-identified clinical and lab data were entered in a specifically designed on-line platform. Co-variables potentially linked to AKI onset, in-hospital and 90-days mortality, were recorded and correlated using a multiple logistic regression model. Results Fifty-seven physicians from 15 countries provided data on 905 patients, most with acceptable basic needs coverage. Median age 64 (50-74) yrs; most of them were male (61%) and mestizos (42%). Comorbidities were present in 77%. AKI was community-acquired in 62%. Dehydration, shock and nephrotoxic drugs were the commonest causes. During their process of care, 77% of patients were assessed by nephrologists. Kidney replacement therapy (KRT) was performed in 29% of cases. In-hospital mortality was 26.5% and independently associated to older age, chronic liver disease, hypotension, shock, cardiac disturbances, hospital-acquired sepsis, KRT and mechanical ventilation. At 90-days follow up partial or complete renal recovery was 81% and mortality 24%. Conclusions AKI was mainly community-acquired, in patients with comorbidities and linked to fluid loss and nephrotoxic drugs. Mortality was high and long-term follow up poor. Notwithstanding, the study shows partially the situation in the participant countries rather than the actual epidemiology of AKI in Latin America and Caribbean, a pending and needed task.
Palavras-chave
Referências
  1. Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413
  2. Daher EF, 2011, AM J TROP MED HYG, V85, P479, DOI 10.4269/ajtmh.2011.11-0080
  3. Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8
  4. FIRMAT J, 1994, RENAL FAILURE, V16, P91, DOI 10.3109/08860229409044850
  5. Fresneda O., 2007, ESTUDIOS PERSPECTIVA, V18
  6. Gabriel DP, 2008, KIDNEY INT, V73, pS87, DOI 10.1038/sj.ki.5002608
  7. Holmes J, 2016, CLIN J AM SOC NEPHRO, V11, P2123, DOI 10.2215/CJN.05170516
  8. Kashani K, 2017, KIDNEY INT REP, V2, P519, DOI 10.1016/j.ekir.2017.03.014
  9. Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9
  10. Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153
  11. Lombardi R, 2008, SEMIN NEPHROL, V28, P320, DOI 10.1016/j.semnephrol.2008.04.001
  12. Lombardi R, 2018, KIDNEY INT REP, V3, P1416, DOI 10.1016/j.ekir.2018.08.003
  13. Lombardi R, 2014, NEPHROL DIAL TRANSPL, V29, P1369, DOI 10.1093/ndt/gfu078
  14. Lucato RV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001182
  15. Mehta RL, 2016, LANCET, V387, P2017, DOI 10.1016/S0140-6736(16)30240-9
  16. Mehta RL, 2015, LANCET, V385, P2616, DOI 10.1016/S0140-6736(15)60126-X
  17. Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5
  18. Palomba H, 2016, J CRIT CARE, V34, P33, DOI 10.1016/j.jcrc.2016.03.018
  19. Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x
  20. Ponce D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126436
  21. Chavez-Iniguez JS, 2018, GAC MED MEX, V154, pS6, DOI 10.24875/GMM.M18000067
  22. Silva Junior Geraldo Bezerra da, 2017, Braz. J. Nephrol., V39, P357, DOI 10.5935/0101-2800.20170066
  23. Szalachman R., 2000, SERIE FINANCIAMIENTO
  24. Vukusich A, 2004, REV MED CHILE, V132, P1355, DOI 10.4067/S0034-98872004001100003